Virtual Screening and in vitro validation of SARS CoV-II Main Protease inhibitors | India Science, Technology & Innovation - ISTI Portal

×

Accessibility Controls

Virtual Screening and in vitro validation of SARS CoV-II Main Protease inhibitors

Implementing Organization

Indian Institute of Technology (IIT), Gandhinagar

Principal Investigator

Dr Sharad Gupta

Associate Professor

Related Research

Quick Information

Area of Research

Pharmaceutical Sciences

Focus Area

Drug repurposing for COVID-19

Start Date

2020

Contact

sharad@iitgn.ac.in; mithunr@iitgn.ac.in

Output

No. of Research Paper

00

Technologies (If Any)

00

No. of PhD Produced

00

Publications

00

No. of Patents

Filed : 00

Grant : 00

Latest Updates

Loading…